GT Biopharma could report Phase 1 trial data later this year, says Roth MKM
GT Biopharma (GTBP) ended 2024 with roughly $4M in cash, enough to fund operations into the second quarter of 2025, Roth MKM tells investors in ...
Roth MKM Sticks to Their Hold Rating for Array Technologies (ARRY)
Roth MKM analyst Philip Shen maintained a Hold rating on Array Technologies (ARRY – Research Report) today and set a price target of $6.00. The ...
Roth Mkm Issues Positive Forecast for Sprouts Farmers Market (NASDAQ:SFM) Stock Price
Sprouts Farmers Market (NASDAQ:SFM – Free Report) had its price target increased by Roth Mkm from $105.00 to $146.00 in a ...
Roth Mkm Issues Positive Forecast for Hasbro (NASDAQ:HAS) Stock Price
Hasbro (NASDAQ:HAS – Free Report) had its price objective lifted by Roth Mkm from $68.00 to $82.00 in a research report sent ...
Hosted on MSN3d
Roth MKM Initiates Coverage of Quanta Services (PWR) with Buy Recommendation
Fintel reports that on February 21, 2025, Roth MKM initiated coverage of Quanta Services (NYSE:PWR) with a Buy recommendation ...
Ads-Tec Energy price target raised to $18 from $14 at Roth MKM, buy on weakness
Roth MKM raised the firm’s price target on Ads-Tec Energy (ADSE) to $18 from $14 and keeps a Neutral rating on the shares.
Hosted on MSN25d
Roth/MKM raises PLBY Group stock rating to Buy, targets $3
On Friday, Roth/MKM analysts reinstated coverage on PLBY Group, Inc. (NASDAQ: PLBY) with a Buy rating and set a price target of $3.00, representing significant upside from the current price of $1.66.
Matador price target raised to $73 from $72 at Roth MKM
Roth MKM raised the firm’s price target on Matador (MTDR) to $73 from $72 and keeps a Buy rating on the shares following the company’s Q4 report. The firm says Matador’s Q1 production guidance is 3% ...